Modeling prostate cancer in the mouse has shown that prostate epithelial cell-specific loss of Pten and TP53 results in aggressive, lethal disease that is significantly more penetrant and rapidly developing than prostate cancer resulting from Pten deletion alone [23], [24]. This evidence concerns the gene TP53 and prostate carcinoma.